Literature DB >> 12376963

Complete nucleotide sequence of a Coxsackievirus B-4 strain capable of establishing persistent infection in human pancreatic islet cells: effects on insulin release, proinsulin synthesis, and cell morphology.

Hong Yin1, Anna-Karin Berg, Jan Westman, Claes Hellerström, Gun Frisk.   

Abstract

The aim of the present investigation was to study the effect of infection of human pancreatic islet cells with a strain (VD2921) of Coxsackie B virus serotype 4 capable of establishing persistent infection in these cells, as well as to sequence the strain, to study the determinants of virulence and persistence. Groups of islets were infected and assessments of proinsulin, insulin content, and virus replication were made. Insulin release in response to high glucose was measured. Infected and control islets displayed a strong insulin response to high glucose 3-4 days as well as 7-8 days post-infection (dpi). At 11-17 dpi, the infected islets did not respond at all to high glucose, and the response of the control islets was at this late time point somewhat reduced. The insulin and proinsulin content of the infected islets did not differ significantly from that of the control islets. TCID(50) titrations showed that the VD2921 strain replicated in the islet cells during the whole study. Electron microscopic examination of infected islets did not reveal any virus-induced changes of cell morphology compared with the controls, although higher magnifications of the infected beta-cells showed virus-like particles in the cytoplasm. These results show that certain strains of Coxsackievirus B-4 in vitro can establish a persistent infection that might mimic, the more gradual loss of beta-cell function seen during the clinical course of autoimmune diabetes. The ability of this Coxsackievirus B-4 strain to establish a persistent infection might be due to substitution of 11 amino acids located at the surface of the structural protein VP1, adjacent to the predicted receptor binding canyon of the virus. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12376963     DOI: 10.1002/jmv.10236

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  21 in total

Review 1.  The role of enterovirus in chronic fatigue syndrome.

Authors:  J K S Chia
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

2.  Persistent infection of thymic epithelial cells with coxsackievirus B4 results in decreased expression of type 2 insulin-like growth factor.

Authors:  Hela Jaïdane; Delphine Caloone; Pierre-Emmanuel Lobert; Famara Sane; Olivier Dardenne; Philippe Naquet; Jawhar Gharbi; Mahjoub Aouni; Vincent Geenen; Didier Hober
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

3.  Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity.

Authors:  Hanna Honkanen; Sami Oikarinen; Noora Nurminen; Olli H Laitinen; Heini Huhtala; Jussi Lehtonen; Tanja Ruokoranta; Minna M Hankaniemi; Valérie Lecouturier; Jeffrey W Almond; Sisko Tauriainen; Olli Simell; Jorma Ilonen; Riitta Veijola; Hanna Viskari; Mikael Knip; Heikki Hyöty
Journal:  Diabetologia       Date:  2017-01-09       Impact factor: 10.122

Review 4.  Immunology in the clinic review series; focus on type 1 diabetes and viruses: how viral infections modulate beta cell function.

Authors:  F A Grieco; G Sebastiani; I Spagnuolo; A Patti; F Dotta
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

Review 5.  Enteroviruses in the pathogenesis of type 1 diabetes.

Authors:  Sisko Tauriainen; Sami Oikarinen; Maarit Oikarinen; Heikki Hyöty
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

6.  Induction of the chemokine interferon-gamma-inducible protein-10 in human pancreatic islets during enterovirus infection.

Authors:  A-K Berg; O Korsgren; G Frisk
Journal:  Diabetologia       Date:  2006-09-13       Impact factor: 10.122

7.  Molecular analysis of an echovirus 3 strain isolated from an individual concurrently with appearance of islet cell and IA-2 autoantibodies.

Authors:  Ciğdem H Williams; Sami Oikarinen; Sisko Tauriainen; Kimmo Salminen; Heikki Hyöty; Glyn Stanway
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

8.  Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1.

Authors:  S J Richardson; P Leete; A J Bone; A K Foulis; N G Morgan
Journal:  Diabetologia       Date:  2012-10-14       Impact factor: 10.122

9.  Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas.

Authors:  Sarah J Richardson; Pia Leete; Shalinee Dhayal; Mark A Russell; Maarit Oikarinen; Jutta E Laiho; Emma Svedin; Katharina Lind; Therese Rosenling; Nora Chapman; Adrian J Bone; Alan K Foulis; Gun Frisk; Malin Flodstrom-Tullberg; Didier Hober; Heikki Hyoty; Noel G Morgan
Journal:  Diabetologia       Date:  2013-11-05       Impact factor: 10.122

10.  Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients.

Authors:  Francesco Dotta; Stefano Censini; Astrid G S van Halteren; Lorella Marselli; Matilde Masini; Sabrina Dionisi; Franco Mosca; Ugo Boggi; Andrea Onetti Muda; Stefano Del Prato; John F Elliott; Antonello Covacci; Rino Rappuoli; Bart O Roep; Piero Marchetti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.